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Abstract With aging, an increased prevalence of a
clustering of metabolic abnormalities has been ob-
served. These abnormalities include obesity, dyslipi-
demia, hypertension, and insulin resistance and are
collectively known as metabolic syndrome (MetS), a
low-grade, systemic, inflammatory condition associat-
ed with an increased risk of cardiovascular disease,
diabetes, and other adverse health outcomes. A num-
ber of studies have demonstrated that centenarians’
offspring have a significant survival advantage and a
lower risk of developing the most important age-
related diseases. They therefore represent one of the
best models with which to study the familiar compo-
nent of human longevity. The aim of this study was to
determine if the offspring of centenarians (n0265
subjects) showed a different prevalence of MetS in
comparison to the offspring of non-long-lived parents
(controls, n0101 subjects). In addition, we assessed
whether centenarians’ offspring showed particular fea-
tures of MetS and a distinct regulation of circulating
adipokines, cytokines, and metabolic mediators. Al-
though the prevalence of MetS was quite similar both
AGE
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in the offspring of centenarians and the controls,
MetS-affected centenarians’ offspring seemed health-
ier, more functionally fit, and had lower resistin levels.
MetS prevalence did not change in centenarians’ off-
spring across resistin, IGF-1, and resistin/IGF-1 ratio
tertiles. On the other hand, in controls, MetS preva-
lence strongly increased across resistin tertiles and in
the third resistin/IGF-1 ratio tertile, indicating a dra-
matic increase in MetS prevalence when the ratio
between these two factors is unbalanced, with high
levels of resistin and low levels of IGF-1.
Keywords Metabolic syndrome . Aging .
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Introduction
With aging, there is a profound modification within
the cytokine network, characterized by a general in-
crease in plasma levels and cell capability to produce
pro-inflammatory cytokines. This leads to a chronic,
low-grade, pro-inflammatory status known as inflam-
maging (Franceschi et al. 2000a, b). This peculiar pro-
inflammatory condition could be the cause or the
effect of the increased prevalence of a clustering of
metabolic abnormalities characterized by an inflam-
matory pathogenesis such as obesity, dyslipidemia,
hypertension, insulin resistance, and type 2 diabetes.
Together, these abnormalities constitute the metabolic
syndrome (MetS) (Das 2004). All the single compo-
nents of MetS and MetS itself are associated with an
increased risk of developing cardiovascular disease,
stroke, brain infarction, diabetes mellitus, and other
age-related diseases (Haffner 2006; Kwon et al. 2006).
It is unclear which of the risk factors that constitute the
MetS contributes most strongly to these adverse out-
comes, although it has been suggested that obesity or
insulin resistance might be responsible (DeStefano et
al. 1993; Sattar et al. 2008). In fact, fat mass accumu-
lation is associated with an elevation of inflammatory
markers, since adipose tissue, and in particular the
visceral fat, is now considered an endocrine organ.
Mature adipocytes are involved in the secretion of a
large number of multifunctional molecules, collective-
ly termed “adipokines” (Yudkin et al. 1999) able to
physiologically modulate the energetic balance of the
organism, lipid and glucose metabolism, immune re-
sponse, and reproductive functionality (Chaldakov et
al. 2003; Rajala and Scherer 2003; Gnacinska et al.
2009). Furthermore, macrophages residing in the adi-
pose tissue may also be a source of pro-inflammatory
factors and may modulate the secretory activity of
adipocytes (Xu et al. 2003). Therefore, adipose tissue
and its age-associated redistribution (Arai et al. 2011)
could play a role in inflammaging by affecting the
adipokines’ network.
Recently, it has been shown that familiar factors
may play an important role in the onset of MetS. In
fact, the offspring of long-lived parents (nonagenar-
ians and centenarians) have a moderately lower prev-
alence of MetS and retain improved glucose tolerance
and enhanced insulin sensitivity (Rozing et al. 2009,
2010; Wijsman et al. 2011; Barzilai et al. 2003) com-
pared to age-matched controls. These observations
suggest that a protective phenotype against MetS and
insulin resistance could be inherited from long-lived
parents and be relevant to healthy aging.
The aim of this study was to determine if
centenarians’ offspring, who are characterized by
“better” aging (Terry et al. 2004a, b; Atzmon et al.
2004; Vitale et al. 2012; Gentilini et al. 2012),
showed a different prevalence of MetS in compar-
ison to age-matched offspring of non-long-lived
parents. In addition, we evaluated whether MetS-
affected centenarians’ offspring displayed particular
features of this metabolic/pro-inflammatory syn-
drome and a peculiar regulation of circulating adi-
pokines, cytokines, and metabolic mediators, in
order to identify a phenotype that could influence
their overall health status.
Materials and methods
Study design and participants
A total of 366 subjects were enrolled from five Italian
cities (Bologna, Milan, Florence, Parma, and Palermo)
and the surrounding areas. The group of centenarians’
offspring consisted of 265 subjects (108 males and 157
females, mean age 70.2±6.6 years) with one centenarian
parent (born in Italy between 1900 and 1908). The
control group consisted of 101 subjects (52 males and
49 females, mean age 70.9±6.0 years) with both parents
(born in Italy between 1900 and 1908) dead before the
average life expectancy at 15 years of age (67 years for
the father and 72 years for the mother) according to
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Italian mortality tables (see website “Human Mortality
Database” of the Max Planck Institute for Demography,
Rostock, Germany: http://www.mortality.org). All the
centenarians’ offspring and offspring of non-long-lived
parents were free living and recruited from Italian pop-
ulation according the above-mentioned strict demo-
graphic criteria. The study protocol was approved by
the Ethical Committee of Sant’Orsola-Malpighi Univer-
sity Hospital (Bologna, Italy).
After obtaining written informed consent, a standard
questionnaire was administered by trained physicians
and nursing staff to collect demographic and lifestyle
data, anthropometric measurements, functional, cogni-
tive and health status, clinical anamnesis, and details on
drug use. Subjects affected by malignant neoplasia and/
or those in therapy with immunosuppressor drugs (like
cyclosporine, methotrexate, glucocorticoids, etc.) or an-
ticoagulant drugs were excluded from the study.
Data collection
Body weight was measured using standard weighing
scales (SECA Mod. 761) calibrated in kilograms.
Height was measured at head level to the nearest
centimeter with the subject standing barefoot, feet
together, using a standard tape measure calibrated in
centimeters. Body mass index (BMI) was calculated as
weight in kilograms divided by the square of the
height in meters (kg/m2). Waist circumference was
measured to the nearest centimeter by wrapping a
flexible steel tape at the level of the umbilicus at the
end of exhalation, with the subject standing.
Past and current disease history was accurately
recorded by addressing the major age-related patholo-
gies: myocardial infarction, stroke, cerebral thrombo-
sis and hemorrhage, hypertension, chronic obstructive
pulmonary disease, hypercholesterolemia, diabetes,
cancer, and chronic renal insufficiency.
Current use of medication (including inspection of
the drugs by the interviewer) was recorded, and the
drugs were grouped into four main categories: cardio-
vascular (antiarrhythmic and/or vasodilator and/or
thrombolytic drugs), antihypertensive (calcium chan-
nel blockers and/or ACE inhibitors and/or diuretics
and/or beta blockers), lipid-lowering (statins and/or
fibrates and/or other hypolipidemic agents), and anti-
diabetic (sulfonylureas and/or biguanides and/or insu-
lin and insulin analogs and/or other oral antidiabetic
association) therapies.
Physical performance was assessed using the Chair
Stand Test protocol to evaluate leg strength and en-
durance by measuring the time it takes to perform five
repetitions of sit-to-stand (Csuka and McCarty 1985).
On the basis of the result obtained, participants were
divided into two groups (able or unable to complete
the test).
Laboratory measurements
Overnight fasting blood samples were obtained early in
the morning. Serum was removed after clotting and
centrifugation at 760×g for 20 min, rapidly frozen and
stored at −80 °C. Serum total and HDL cholesterol,
triglycerides, and glycemia were measured using stan-
dard hematology methods. Serum LDL concentration
was calculated using the Friedewald equation: LDL 0
total cholesterol−HDL−(triglycerides / 5). Serum insulin
was measured using a chemiluminescent immunoassay
(LIAISON® Insulin assay, DiaSorin, Saluggia, Italy),
and samples were analyzed on the LIAISON® Analyzer
(DiaSorin). Insulin resistance status was assessed using
the homeostasis model assessment of insulin resistance
(HOMA-IR), according to the previously described for-
mula (Matthews et al. 1985): insulin (in microunits per
milliliter) × glucose (in millimoles per liter)/22.5. Total
IGF-I was assayed using a one-step sandwich chemilu-
minescence immunoassay after prior separation of IGF-I
from binding proteins on the LIAISON® analyzer.
Plasma was obtained from blood within 2 h of veni-
puncture by centrifugation at 2,000×g for 20min. It was
rapidly frozen and stored at −80 °C. Plasma levels of IL-
6, IL-10, TNF-α trimer, serum amyloid A, adiponectin,
leptin, and resistin were measured by multiplex sand-
wich ELISA technology (SearchLight, Aushon Biosys-
tems, Billerica, MA) according to the manufacturer’s
instructions. Samples, standards, and reagents were dis-
pensed in the plates using a standardized technique
employing a robotic liquid handling system with 16
channels (Microlab® STAR, Hamilton Robotics, Reno,
NV). Plasma TGF-β1 concentration was determined
using a commercial ELISA kit (DRG Instruments
GmbH, Marburg, Germany), according to the manufac-
turer’s instructions. TGF-β1 concentration was detected
and quantified using a Synergy™ HT Multi-Detection
Microplate Reader (BioTek® Instruments, Winooski,
VT). Plasma fibrinogen was measured using a fibrin
polymerization assay (Boehringer Biochemia). Plasmin-
ogen activator inhibitor type 1 activity (PAI-1) was
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measured using a chromogenic method (Biopool,
Umea, Sweden).
Subjects who have recently (1 week prior to the
study) used medication that could influence the in-
flammatory response, such as steroid or nonsteroidal
anti-inflammatory drugs and immunomodulant agents,
were excluded from adipokine and cytokine analysis.
Definition of MetS
MetS was defined according to the Third Report of the
National Cholesterol Education Program Expert Panel
on Detection, Evaluation, and Treatment of High
Blood Cholesterol in Adults (NCEP-ATP III) criteria
(Expert Panel on Detection, Evaluation, and Treatment
of High Blood Cholesterol in Adults 2001). Based on
this definition, the subjects with MetS were identified
as having any combination of three or more of the
following components: abdominal obesity (waist cir-
cumference >102 cm for men and >88 cm for women),
high triglycerides (plasma triglycerides ≥150 mg/dl or
subjects on lipid-lowering therapy), low HDL choles-
terol (<40 mg/dl for men and <50 mg/dl for women),
hypertension (blood pressure ≥130 or ≥85 mmHg or
subjects on hypotensive treatment), and hyperglyce-
mia (fasting plasma glucose ≥110 mg/dl or subjects on
antidiabetic therapy).
Statistical analysis
A preliminary evaluation of the differences between
MetS-affected centenarians’ offspring and offspring of
non-long-lived parents was performed using the chi-
square test for categorical variables and the indepen-
dent samples’ t test or nonparametric Mann–Whitney
U test for continuous variables (data not shown). Bi-
nary logistic regression was performed to examine the
relationship between dichotomized variables (MetS
prevalence, MetS components, ability to perform chair
stand test, prevalence of past and current diseases, and
drug therapies) and offspring status. The univariate
general linear model was used to examine the relation-
ship between continuous variables (BMI, lipids, me-
tabolism, insulin resistance, and inflammatory
markers) and offspring status. Multiple regression
model was used to test the association between meta-
bolic mediators and prevalence of MetS adjusted for
BMI. All analyses were executed using SPSS 19.0 for
windows (SPSS Inc., Chicago, IL, USA).
Results
Table 1 displays the baseline characteristics of the study
population. No difference in age or gender distribution
was observed between centenarians’ offspring and off-
spring of non-long-lived parents (controls). BMI was
higher in the controls (p00.003), while no differences
were observed in the distribution of the NCEP-ATP III
criteria in the entire population. Ninety-four MetS-
affected centenarians’ offspring and 34 MetS-affected
controls were identified, and the prevalence of the MetS
was found to be quite similar in the two groups (35.5 vs.
33.7 %, p00.910).
Table 2 shows the baseline and lifestyle features of the
MetS-affected subjects. TheMetS-affected centenarians’
offspring and MetS-affected controls were comparable
in age (71.1±5.6 vs 72.2±5.7 years, p00.329), gender
distribution (p00.745), level of education (p00.307),
BMI (p00.066), proportion of current and former smok-
ers (p00.473 and p00.969, respectively), and proportion
of subjects consuming alcohol (p00.642).
The health status of MetS-affected centenarians’ off-
spring and controls was therefore compared (Table 3).
The MetS-affected centenarians’ offspring had a signif-
icantly lower prevalence of past cardiovascular events
(myocardial infarction, stroke, cerebral thrombosis/
hemorrhage; p00.033), hypercholesterolemia (p0
0.015), and renal insufficiency (p00.027) than the
MetS-affected controls. The prevalence of hypertension
(p00.066), chronic obstructive pulmonary disease (p0
0.201), and past cancer (p00.152) was also lower in the
MetS-affected centenarians’ offspring, but these differ-
ences were not statistically significant. Moreover, in
MetS-affected centenarians’ offspring, the mean num-
ber of prescribed drugs was significantly lower (p0
0.000); in particular, a significantly lower percentage
of subjects on cardiovascular (p00.005) and lipid-
lowering therapy (p00.000) was found. The percentage
of MetS-affected centenarians’ offspring on hyperten-
sive therapy was also lower but this difference was not
significant. Considering physical performance, a higher
percentage of MetS-affected centenarians’ offspring
was able to perform chair stand test (p00.002) (Table 3).
Thus, given that MetS-affected centenarians’ off-
spring appeared healthier and more functionally fit than
MetS-affected controls, we evaluated the constituents of
the MetS affecting these subjects by analyzing the dis-
tribution of the NCEP-ATP III criteria (Fig. 1). Within
the MetS-affected centenarians’ offspring group,
AGE
hypertension ranked the highest (95.6 %), followed by
high plasma triglycerides (71.3 %), abdominal obesity
and low HDL cholesterol (68.8 and 67.0 %, respective-
ly), and high fasting glucose/antidiabetic medications
use (36.2 %). Hypertension also ranked the highest
(97.1 %) in the MetS-affected controls, but it was fol-
lowed by abdominal obesity (85.3 %), high plasma
triglycerides (79.4 %), low HDL cholesterol, and high
fasting glucose/antidiabetic medications use (48.5 and
41.2 %, respectively). In particular, a lower percentage
of abdominal obesity and a higher proportion of low
HDL were found in MetS-affected centenarians’ off-
spring even if this difference was not statistically signif-
icant (p00.070 and p00.060, respectively).
Table 4 shows the lipid profile, insulin resistance
markers, inflammatory profile, and metabolic media-
tors (adipokines) in MetS-affected centenarians’
offspring and controls. MetS-affected centenarians’
offspring had lower levels of HDL cholesterol and
higher levels of LDL cholesterol, while there were
no differences in total cholesterol, triglycerides, insu-
lin, glycemia, and HOMA between the two groups.
MetS-affected centenarians’ offspring had lower lev-
els of resistin in comparison to MetS-affected controls
(p00.008), while no differences in the inflammatory
parameters (C-reactive protein, fibrinogen, PAI-1, se-
rum amyloid A protein, IL-6, and TNF-α, TGF-β1),
adiponectin, leptin, IGF-1, leptin/adiponectin, and
resistin/IGF-1 ratio were found.
To investigate whether the higher abdominal obesi-
ty observed in controls may play a role in the in-
creased levels of resistin found in these subjects, a
linear regression analysis was performed between
plasma levels of resistin and waist circumference. In
Table 2 Baseline features of
MetS-affected centenarians’ off-
spring and controls
MetS-affected
centenarians’ offspring
MetS-affected
controls
p value
n 94 34
Age, years, mean ± S.D. 71.1±5.6 72.2±5.7 0.329
Females, n (%) 61 (64.9) 21 (61.8) 0.745
Education, years, mean ± S.D. 9.9±5.1 9.0±3.5 0.307
BMI, kg/m2, mean ± S.D. 29.2±4.2 30.8±4.3 0.066
Lifestyle
Current smokers, n (%) 14 (15.2) 7 (20.6) 0.473
Former smokers, n (%) 43 (55.1) 15 (55.6) 0.969
Daily alcohol consumption, n (%) 44 (48.4) 17 (53.1) 0.642
Table 1 Distribution of MetS components and prevalence of MetS in centenarians’ offspring and controls
Centenarians’ offspring Controls O.R. (95 % C.I.) p value
n 265 101
Age, years ± S.D. 70.2±6.6 70.9±6.0 0.98 (0.95–1.02) 0.338
Females, n (%) 157 (59.2) 49 (48.5) 1.54 (0.97–2.45) 0.065
BMI, kg/m2, mean ± S.D.a 26.5±4.4 28.1±4.2 1.08 (1.03–1.14) 0.003
Hypertension, n (%)a 224 (84.5) 88 (87.1) 0.80 (0.41–1.57) 0.522
High triglycerides, n (%)a 96 (36.2) 46 (45.5) 0.67 (0.42–1.06) 0.088
Abdominal obesity, n (%)a 92 (35.2) 43 (43.0) 0.66 (0.41–1.07) 0.089
Low HDL cholesterol, n (%)a 81 (31.0) 22 (22.2) 1.49 (0.86–2.57) 0.154
Hyperglycemia, n (%)a 40 (15.1) 19 (18.8) 0.77 (0.42–1.40) 0.389
MetS prevalence, n (%)a 94 (35.5) 34 (33.7) 1.03 (0.63–1.68) 0.910
O.R. odds ratio, C.I. confidence interval
a Gender-adjusted
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controls, resistin was positively associated with waist
circumference (p00.013), while no association was
found in centenarians’ offspring (p00.244) (Fig. 2).
In order to evaluate the influence of metabolic
mediators on MetS prevalence in the two groups,
subjects were stratified according to tertiles of leptin,
adiponectin, leptin/adiponectin ratio, resistin, IGF-1,
and resistin/IGF-1 ratio. As shown in Fig. 3, MetS
prevalence progressively increased significantly
across leptin tertiles in both groups (p<0.001), while
it decreased across adiponectin tertiles in both groups,
with a significant decrease observed only in the cen-
tenarians’ offspring group (p<0.001). Moreover, MetS
prevalence increased significantly across leptin/adipo-
nectin ratio tertiles in both groups (p<0.001). As
shown in Fig. 4, MetS prevalence did not change
across resistin and IGF-1 tertiles in centenarians’ off-
spring, while it increased significantly across the resis-
tin tertile (p<0.001) and tended to decrease across
IGF-1 tertiles in controls. MetS prevalence did not
change in centenarians’ offspring across resistin/IGF-
1 ratio tertiles, while in controls, MetS prevalence
strongly increased in the third tertile comprising the
highest levels of resistin and the lowest levels of IGF-1
(p<0.001). All these associations remained significant
after adjusting for BMI, except for leptin and resistin
in controls probably due to the sample size.
Discussion
In this study, we show that the prevalence of MetS and
all its components is quite similar in the population of
centenarians’ offspring and the population of offspring
of non-long-lived parents we recruited. These data are
in contrast with a previous study reporting that off-
spring of long-lived parents have a lower prevalence
of MetS than their partners despite having a compara-
ble body composition (Rozing et al. 2010). However,
the results of the present paper show that in the pres-
ence of MetS, centenarians’ offspring have a signifi-
cantly lower prevalence of some important age-related
Table 3 Prevalence of major age-related diseases, pharmacological therapies, and physical performance in MetS-affected centenarians’
offspring and controls
MetS-affected
centenarians’ offspring
MetS-affected
controls
O.R. (95 % C.I.) p value
n 94 34
Pathologies
Past myocardial infarction, stroke, cerebral
thrombosis/hemorrhage, n (%)
10 (10.8) 9 (26.5) 0.33 (0.12–0.92) 0.033
Hypertension, n (%) 58 (61.7) 27 (79.4) 0.42 (0.16–1.06) 0.066
Chronic obstructive pulmonary disease, n (%) 3 (3.2) 3 (8.8) 0.34 (0.15–0.97) 0.201
Hypercholesterolemia, n (%) 35 (37.2) 21 (61.8) 0.37 (0.16–0.82) 0.015
Diabetes, n (%) 22 (23.4) 9 (26.5) 0.85 (0.34–2.09) 0.721
Past cancer, n (%) 8 (8.5) 6 (17.6) 0.43 (0.14–1.36) 0.152
Chronic renal insufficiency, n (%) 1 (1.1) 4 (11.8) 0.08 (0.01–0.75) 0.027
Pharmacological therapy
Number of prescribed medicines, mean ± S.D. 3.4±2.4 6.2±2.7 0.68 (0.57–0.81) 0.000
Cardiovascular therapy, n (%) 29 (30.9) 20 (58.8) 0.31 (0.14–0.70) 0.005
Anti-hypertensive therapy, n (%) 58 (61.7) 27 (79.4) 0.42 (0.16–1.06) 0.066
Lipid-lowering therapy, n (%) 27 (28.7) 22 (64.7) 0.22 (0.10–0.51) 0.000
Anti-diabetic therapy, n (%) 15 (16.0) 8 (23.5) 0.62 (0.23–1.62) 0.327
Physical performance
Able to perform chair stand test, n (%) 87 (94.6) 24 (72.7) 6.52 (2.00–21.30) 0.002
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diseases such as past cardiovascular events, hyperten-
sion, hypercholesterolemia, and renal insufficiency
than do the offspring of non-long-lived parents. This
is confirmed by the fact that MetS-affected centenar-
ians’ offspring took less drugs and, in particular, a
lower percentage of them were on cardiovascular,
lipid-lowering, and antihypertensive therapies. In ad-
dition, the chair stand test indicates that almost all the
centenarians’ offspring maintain good physical fitness
even in the presence of MetS, while in controls, this
percentage is significantly lower. These findings col-
lectively indicate that MetS-affected centenarians’ off-
spring are healthier and more functionally fit than
MetS-affected controls, despite being comparable in
age, gender distribution, and education level. Some
studies report that centenarians generally avoid bad
lifestyle habits (Galioto et al. 2008) and so too do their
progeny, as demonstrated by Terry et al. (2007). In
fact, the offspring of long-lived parents had a lower
prevalence of some risk factors such as smoking. In
contrast, in this study, no significant differences were
found between groups with respect to lifestyle risk
factors (smoking and alcohol consumption) showing
that the better health status observed in MetS-
affected centenarians’ offspring might not depend
on a healthier lifestyle transmitted from their cen-
tenarian parent.
Therefore, a possible explanation for the healthier
condition of MetS-affected centenarians’ offspring
could be attributed to the composition of MetS. In fact,
the prevalence of NCEP-ATP III criteria in MetS-
affected centenarians’ offspring and controls seems
quite different and, in particular, we observed a trend
towards a lower prevalence of abdominal obesity in
centenarians’ offspring with respect to controls. Ab-
dominal obesity and the presence of visceral fat are
increasingly recognized as major risk factors for cardio-
vascular diseases, and they also promote insulin resis-
tance, dyslipidemia, and hypertension (Czernichow et
al. 2011; de Koning et al. 2007). These observations,
together with the fact that MetS-affected controls
showed a higher proportion of past cardiovascular
events, hypertension, and hypercholesterolemia, could
suggest that a form of MetS where abdominal obesity is
one of the major determinants could be associated with a
worse outcome.
MetS-affected centenarians’ offspring seem to have
an unfavorable lipid profile, considering that they have
Fig. 1 Prevalence of MetS components in MetS-affected centenarians’ offspring and controls. Data were expressed as percentage, and the
statistical analysis was performed by chi-square test
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lower levels of HDL cholesterol and higher levels of
LDL cholesterol in comparison to controls. These data
are in contrast to the data obtained from a previous
study which showed that the offspring of nonagenar-
ian siblings displayed a more beneficial lipid profile
(Vaarhorst et al. 2011). However, this result may be
partly explained by the fact that less than half of the
MetS-affected centenarians’ offspring were on lipid-
lowering therapy compared to the MetS-affected con-
trols. This finding may indicate that in centenarians’
offspring, a delayed onset or milder forms of hyper-
cholesterolemia and hypertriglyceridemia can occur,
which do not yet require pharmacological treatment
with lipid-lowering agents.
In this study, we did not find significant differences in
insulin resistance markers, in the prevalence of diabetes,
Table 4 Lipid profile, insulin resistance markers, metabolic mediators, and inflammatory profile of MetS-affected centenarians’
offspring and controls
MetS-affected centenarians’
offspring
MetS-affected
controls
O.R. (95 % C.I.) p value
n 94 34
Lipid profile
Total cholesterol, mg/dl, mean (S.D.) 200.2 (43.5) 190.0 (36.4) 1.00 (1.00–1.02) 0.229
HDL cholesterol, mg/dl, median (25th–75th) 42.0 (35.0−50.0) 48.0 (38.5−71.0) 0.97 (0.94–0.99) 0.005
LDL cholesterol, mg/dl, mean (S.D.) 121.6 (41.8) 103.6 (34.3) 1.01 (1.00–1.02) 0.031
Triglycerides, mg/dl, mean (S.D.) 170.4 (82.2) 158.9 (69.0) 1.00 (1.00–1.01) 0.474
Insulin resistance markers
Glycemia, mmol/l, mean (S.D.) 106.0 (42.3) 110.8 (41.0) 1.00 (0.99–1.01) 0.567
Insulin, μIU/ml, mean (S.D.) 17.2 (12.7) 13.4 (5.7) 1.05 (0.99–1.12) 0.106
HOMA-IR index, mean (S.D.) 4.5 (3.8) 3.8 (2.8) 1.06 (0.92–1.23) 0.407
Inflammatory profilea
C-reactive protein, mg/l, mean (S.E.M.) 3.2 (0.5) 2.6 (0.4) 1.04 (0.92–1.18) 0.535
Fibrinogen, mg/ml, mean (S.E.M.) 3.6 (0.2) 3.1 (0.3) 1.27 (0.90–1.79) 0.173
PAI-1act, IU/ml, mean (S.E.M.) 2.5 (0.2) 2.2 (0.3) 1.08 (0.78–1.50) 0.633
Serum amyloid A protein, μg/ml, mean (S.E.M.) 169.4 (22.6) 116.7 (20.4) 1.00 (1.00–1.01) 0.229
IL-6, pg/ml, mean (S.E.M) 36.9 (6.8) 52.9 (14.5) 1.00 (0.99–1.00) 0.283
TNF-α, pg/ml, mean (S.E.M) 39.7 (14.6) 67.7 (29.5) 1.00 (1.00–1.00) 0.383
IL-10, pg/ml, mean (S.E.M) 5.2 (0.8) 6.1 (1.0) 0.99 (0.94–1.04) 0.633
TGF-β1, pg/ml, mean (S.E.M.) 5.5 (0.4) 6.1 (1.0) 0.97 (0.89–1.07) 0.584
Metabolic mediatorsa
Leptin, ng/ml, mean (S.E.M.) 33.1 (2.8) 35.7 (5.6) 1.00 (0.98–1.01) 0.649
Adiponectin, μg/ml, mean (S.E.M.) 31.6 (2.6) 35.7 (5.4) 0.99 (0.98–1.01) 0.454
Resistin, ng/ml, median (25th–75th) 8.7 (6.6–11.7) 11.4 (8.3–16.1) 0.87 (0.81–0.95) 0.008
IGF-1, ng/ml, mean (S.E.M.) 117.7 (4.9) 121.2 (9.4) 1.00 (0.98–1.01) 0.736
Leptin/adiponectin ratio, mean (S.E.M.) 2.1 (0.6) 1.8 (0.5) – 0.767b
Resistin/IGF-1 ratio, mean (S.E.M.) 0.1 (0.0) 0.1 (0.0) – 0.815b
a Five centenarians’ offspring and four controls were excluded because they were using steroid or nonsteroidal anti-inflammatory drugs
and/or immunomodulant agents the week before blood sampling. p values are obtained by regression analysis
p values are obtained by regression analysis and bMann Whitney test
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or in the use of antidiabetic therapy between centenar-
ians’ offspring and offspring of non-long-lived parents
with MetS. A previous study demonstrated a preserved
whole-body insulin sensitivity in healthy centenarians
Centenarians offspring Controls  
).I.C%59(.R.Op).I.C%59(.R.Op
nitpeL
1st Tertile  (≤8.8 ng/ml)  1 - 1 - 
2nd Tertile (8.9-23.6 ng/ml) 0.053 2.23 (0.99-5.01) 0.323 2.01 (0.50-8.09) 
3rd Tert ile (≥23.7 ng/ml) 0.001 4.36 (1.90-9.99) 0.061 3.85 (0.94-15.82) 
Adiponectin     
1st Tertile  (≤22.0 µg/ml)  1 - 1 - 
2nd Tertile (22.1-48.2 µg/ml) 0.002 0.31 (0.15-0.66) 0.423 0.60 (0.18-2.07) 
3rd Tert ile (≥48.3 µg/ml) 0.013 0.38 (0.17-0.81) 0.597 0.71 (0.20-2.50) 
Leptin/Adiponectin ratio     
1st Tertile  (≤0.3) 1 - 1 - 
2nd Tertile (0.4-0.8) 0.016 2.93 (1.23-7.01) 0.423 0.60 (0.18-2.07) 
3rd Tert ile (≥0.9) 0.000 6.57 (2.62-16.48) 0.036 5.09 (1.11-23.34) 
a
d
b c
Fig. 3 MetS prevalence for centenarians’ offspring and controls
in leptin (a), adiponectin (b), and leptin/adiponectin (c) ratio
tertiles. **p<0.01, for the chi-square test. d Multiple regression
analysis showing the association between metabolic mediators
tertiles and MetS prevalence adjusted for BMI. O.R. odds ratio,
C.I. confidence interval
Fig. 2 Linear regression between resistin and waist circumference in centenarians’ offspring and controls
AGE
(Paolisso et al. 1996) and recent papers have reported
that subjects with familial predisposition for healthy
longevity showed enhanced glucose tolerance and
higher whole-body insulin sensitivity when compared
to a control group similar in age, sex, and body compo-
sition (Rozing et al. 2009, 2010; Wijsman et al. 2011).
However, cross-sectional data from the Italian popula-
tion showed the highest prevalence of insulin resistance
(determined using the homeostasis model assessment) at
80–90 years (Paolisso et al. 2001). Therefore, a reeval-
uation of the parameters related to insulin resistance in
the same subjects when older could reveal some signif-
icant differences.
The pathogenesis of MetS and of the metabolic ab-
normalities associated with it has a strong inflammatory
component, and the presence and severity of this syn-
drome are tightly associated with markers of systemic
inflammation. During aging, the fat redistribution and,
in particular, the accumulation of central fat could con-
tribute to the low-grade pro-inflammatory status mainly
due to pro-inflammatory molecules (cytokines and adi-
pokines) produced by adipocytes and by macrophages
infiltrating adipose tissue (Arai et al. 2011; You et al.
2008). For this reason, we decided to evaluate the levels
of the main pro- and anti-inflammatory markers. More-
over, Atzmon et al. (2008) demonstrated that adiponec-
tin levels were significantly greater in ≥95-year-old
subjects and their offspring compared to controls, sug-
gesting that inherited factors play a role in determining
adiponectin levels. In fact, a recent paper showed that
the levels of some adipokines are significantly transmit-
ted from parent to offspring (Al-Daghri et al. 2011).
The analysis of inflammatory and metabolic media-
tors showed that MetS-affected centenarians’ offspring
had lower levels of resistin in comparison to MetS-
affected controls. In humans, data on the role of resistin
Centenarians offspring Controls  
p O.R. (95% C.I.) p O.R. (95% C.I.) 
nitsiseR
1st Tertile ( ≤7.6 ng/ml) 1 - 1 - 
2nd Tertile (7.89-11.2 ng/ml) 0.868 1.06 (0.51-2.19) 0.598 1.46 (0.36-6.02) 
3rd Tertile ( ≥11.3 ng/ml) 0.233 0.63 (0.30-1.34) 0.090 3.29 (0.83-13.04) 
1-FGI
1st Tertile ( ≤100.1 ng/ml) 1 - 1 - 
2nd Tertile (100.2-136.7 ng/ml) 0.437 0.71 (0.30-1.68) 0.176 0.24 (0.03-1.88) 
3rd Tertile ( ≥136.8 ng/ml) 0.912 1.05 (0.42-2.64) 0.109 0.23 (0.04-1.39) 
Resistin/IGF-1 ratio     
1st Tertile ( ≤0.06) 1 - 1 - 
2nd Tertile (0.07-0.11) 0.939 1.04 (0.37-2.94) 0.189 0.09 (0.00-3.22) 
3rd Tertile ( ≥0.12) 0.954 1.03 (0.39-2.73) 0.010 19.13 (1.98-184.95) 
a
d
b c
Fig. 4 MetS prevalence for centenarians’ offspring and controls
in resistin (a), IGF-1 (b), and resistin/IGF-1 (c) ratio tertiles. **p<
0.01, for the chi-square test. d Multiple regression analysis
showing the association between metabolic mediators tertiles and
MetS prevalence adjusted for BMI. O.R. odds ratio, C.I. confi-
dence interval
AGE
in insulin sensitivity and obesity are still controversial
but a positive correlation has been found between this
molecule and pro-inflammatory factors in adults with
pathophysiological conditions such as atherosclerosis,
renal disease, and obesity (Savopoulos et al. 2011).
Furthermore, it has been tagged as a potential MetS
marker. Since this pro-inflammatory and atherogenic
adipokine is mostly produced by macrophages infiltrat-
ing visceral fat and is correlated with cardiovascular risk
and insulin resistance, in the present paper, we showed
that there was no association between the levels of
resistin and abdominal obesity, as evaluated by waist
circumference in centenarians’ offspring. On the con-
trary, in the offspring of non-long-lived parents, resistin
was positively associated with waist circumference. In
view of this finding, we propose that abdominal fat
tissue in the offspring of non-long-lived parents may
have a different cellular composition, with a higher
proportion of infiltrating macrophages. These subjects
therefore have a greater predisposition to produce pro-
inflammatory molecules such as resistin, thus explain-
ing the increased prevalence of cardiovascular events,
hypertension, and hypercholesterolemia in MetS-
affected controls.
A plethora of data indicate the involvement of leptin
and adiponectin in obesity, MetS, and cardiovascular
disease. In particular, elevated leptin levels and de-
creased levels of adiponectin have been described in
this context (Palomer et al. 2005; Bik and Baranowska
2009; Harwood 2012; Bremer et al. 2011; Cicero et al.
2011; You et al. 2008). We showed that the prevalence
of MetS progressively increased across leptin levels and
leptin/adiponectin ratio and decreased across adiponec-
tin levels in both groups. These observations confirmed
that high levels of leptin accompanied by low levels of
adiponectin are associated with MetS and that these
adipokines seem to influence MetS prevalence in a very
similar way in centenarians’ offspring and offspring of
non-long-lived parents.
On the contrary, the analysis of MetS prevalence
across resistin and IGF-1 tertiles revealed some intrigu-
ing differences between the two groups.While there was
no change in MetS prevalence across the resistin and
IGF-1 tertiles in centenarians’ offspring, it increased
significantly across the resistin tertiles in controls and
tended to decrease across IGF-1 tertiles. Even though
resistin has been recognized as an indicator of MetS in
several studies (Malo et al. 2011; Gupta et al. 2011;
Aquilante et al. 2008), high levels of resistin did not
seem to influence the risk for this condition in centenar-
ians’ offspring. Recent papers have shown that lower
levels of IGF-1 are associated with insulin resistance
and MetS (Lam et al. 2010; Oh et al. 2012; Succurro et
al. 2008; Arai et al. 2009). Whether this association is
independent of adipokines and/or hormones remains
controversial. In this paper, we show that while the
resistin/IGF-1 ratio does not influence MetS prevalence
in centenarians’ offspring, an impaired balance among
these mediators appears to greatly affect MetS preva-
lence in the offspring of non-long-lived parents. In
particular, a dramatic increase of MetS prevalence was
observed in controls with the resistin/IGF-1 ratio shifted
towards high levels of resistin and low levels of IGF-1,
even after adjusting for BMI. Despite the importance of
resistin in determining insulin resistance and cardiovas-
cular risk, relatively little is known about the effect of
IGF-1 on the control of resistin production and action.
Chen et al. (2005) demonstrated that IGF-1 is able to
suppress resistin mRNA expression and protein release
in 3T3-LI adipocytes in a dose- and time-dependent
manner. In view of this finding, we hypothesized that
in the MetS-affected offspring of non-long-lived parents
belonging to the third tertile of the resistin/IGF-1 ratio,
the low levels of IGF-1 may fail to inhibit resistin
expression leading to increased level of resistin and
contributing to the dramatic increase of MetS preva-
lence. On the contrary, in centenarians’ offspring, pecu-
liar genetic mechanisms could be involved in the fine
regulation of the complex adipokine network and IGF-1
pathway. Further analyses are needed to fully under-
stand the role of the balance between IGF-1 and resistin
in MetS and related diseases taking into account the
genetic background that seems to play a role on the
modulation of the complex interaction between metab-
olism and inflammation.
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